Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Peg-interferon Treatment for Nucleos(t)Ide Analogues Suppressed Chronic Hepatitis B Patients With Low Level Hepatitis Surface Antigen

NCT04035837 is registered in ClinicalTrials.gov with Third Affiliated Hospital, Sun Yat-Sen University as lead sponsor.

NCT NCT04035837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04035837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Peg-interferon Treatment for Nucleos(t)Ide Analogues Suppressed Chronic Hepatitis B Patients With Low Level Hepatitis Surface Antigen
Lead sponsor
Third Affiliated Hospital, Sun Yat-Sen University
Phase
Phase 4
Overall status
Active, not recruiting
Start date
May 16, 2018
Completion date
June 30, 2026
Enrollment
30,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, chronic